| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.59B | 19.95B | 21.74B | 26.51B | 23.58B | 23.09B |
| Gross Profit | 3.72B | 2.64B | 4.61B | 5.75B | 5.34B | 4.45B |
| EBITDA | 1.47B | 1.38B | 2.85B | 4.33B | 2.97B | 2.55B |
| Net Income | 286.69M | -788.08M | 1.38B | 2.67B | 1.74B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 49.70B | 52.38B | 49.27B | 49.64B | 50.21B | 42.33B |
| Cash, Cash Equivalents and Short-Term Investments | 14.22B | 15.32B | 14.48B | 14.03B | 13.85B | 10.53B |
| Total Debt | 7.38B | 7.57B | 7.53B | 7.77B | 8.02B | 5.03B |
| Total Liabilities | 16.15B | 18.12B | 14.52B | 16.55B | 20.16B | 14.84B |
| Stockholders Equity | 33.51B | 34.25B | 34.75B | 33.09B | 30.06B | 27.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 460.96M | -676.82M | -334.50M | -89.00M | -6.38B |
| Operating Cash Flow | 0.00 | 1.09B | -322.68M | 388.05M | 2.25B | 1.82B |
| Investing Cash Flow | 0.00 | 1.14B | 1.12B | -1.37B | -1.42B | -10.00B |
| Financing Cash Flow | 0.00 | -772.27M | -1.06B | -822.86M | 2.48B | 4.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥22.87B | 46.66 | ― | 2.77% | -4.47% | -24.47% | |
65 Neutral | ¥18.81B | 8.12 | ― | 1.73% | 26.09% | ― | |
65 Neutral | ¥18.90B | 10.67 | ― | ― | -2.84% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥25.76B | -53.89 | ― | 3.56% | -3.85% | -45.64% | |
59 Neutral | ¥30.69B | 4.17 | ― | 2.13% | 1.13% | -66.14% | |
51 Neutral | ¥23.82B | 47.30 | ― | 1.10% | 9.21% | -46.66% |